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Abstract 28 
 29 
Human neutrophils contribute to the regulation of inflammation via the generation of 30 
a range of cytokines that affect all elements of the immune system. Here, we 31 
investigated their ability to express some of the members of the IL-12 family after 32 
incubation with TLR8 agonists. Highly pure human neutrophils were thus incubated 33 
for up to 48 h with or without, R848, or other TLR8 agonists, to then measure the 34 
expression levels of transcripts and proteins for IL-12 family member subunits by 35 
RNA-seq, RT-qPCR and ELISA. We show a TLR8-mediated inducible expression of 36 
IL12B and IL23A, but not IL12A, mRNA, which occurs via chromatin remodelling 37 
(as assessed by ChIP-seq), and subsequent production of IL-23 and IL-12B, but no 38 
IL-12, proteins. Induction of IL-23 requires endogenous TNFD, as both mRNA and 39 
protein levels were blocked in TLR8-activated neutrophils via a TNFD-neutralizing 40 
antibody. We also show that supernatants from TLR8-activated neutrophils, but not 41 
autologous monocytes, induce the differentiation of Th17 cells from naïve T cells in 42 
an IL-23-dependent fashion. This study unequivocally demonstrates that highly pure 43 
human neutrophils express and produce IL-23, further supporting the key roles played 44 
by these cells in the important IL-17/IL-23 network and Th17 responses.  45 
 46 
  47 
INTRODUCTION 48 
Neutrophils are currently recognized as potential sources of cytokines, 49 
including chemokines and growth factors1. Neutrophil-derived cytokines not only 50 
regulate inflammation and immunity, but also orchestrate a variety of physiological 51 
processes such as haematopoiesis, angiogenesis and fibrogenesis, as well as 52 
pathological conditions such as infectious, inflammatory, autoimmune or neoplastic 53 
diseases2-4. Circulating blood neutrophils from healthy individuals do not normally 54 
express cytokines, but can generate them in response to stimulus-specific 55 
environmental signals1. Many ligands can activate cytokine expression by human 56 
neutrophils, for instance microbial factors such as pathogen-associated molecular 57 
patterns (PAMPs) binding to pattern recognition receptors (PRR), including Toll-like 58 
receptors (TLRs)5, (RIG-I)6, 7 and DNA sensors7-9, or host-generated cytokines. In 59 
addition, neutrophil-derived factors can themselves enhance/generate additional 60 
cytokine expression via autocrine feedback loops10-12.  61 
We recently identified R848 and CL075 as very powerful agonists able to 62 
trigger a remarkable extracellular production of cytokines, including TNFD, IL-6, G-63 
CSF and CCL2311, 13, 14. R848 and CL075 are synthetic compounds that in human 64 
neutrophils specifically act via TLR8, since TLR7, their other receptor, is absent and 65 
not inducible following cell activation 5, 11, 14. Interestingly, by investigating the 66 
molecular pathways leading to the expression of IL-6 mRNA – an IκBζ-dependent 67 
gene -, we identified a previously undescribed mechanism of cytokine induction in 68 
human neutrophils, resulting from chromatin remodelling11. Specifically, we observed 69 
that the induction of IL-6 transcription by R848 depended on an inducible 70 
remodelling of chromatin at the IL-6 genomic locus, turning it from an “inactive” to 71 
an “active” configuration11. We also observed that, among the IκBζ-dependent 72 
genes, transcripts for IL-12B (corresponding to the p40 subunit of the IL-12 73 
cytokine family) were greatly induced in TLR8-treated neutrophils11. However, we 74 
did not further investigate whether IL12B mRNA was converted into protein, 75 
and/or whether other members of the IL-12 cytokine family to which p40 associates 76 
are expressed/produced by TLR8-activated neutrophils. IL12B is a E-chain of the 77 
IL-12 family of heterodimeric cytokines that can assemble with some D-chains of 78 
the same family, such as IL23A (the p19 subunit), and IL12A (the p35 subunit), to 79 
generate the heterodimers IL-12 (IL12A plus IL12B, which form the p70 complex) 80 
and IL-23 (IL23A plus IL12B)15. In addition, human IL-12B can also form 81 
homodimers that bind to the IL-12 receptor but these do not mediate any biologic 82 
activity16. 83 
Because of the critical roles of the IL-12 family members in innate and 84 
adaptive immunity17, 18, we specifically investigated whether human neutrophils 85 
activated via TLR8 express/produce IL-12 and/or IL-23. We report that TLR8-treated 86 
neutrophils, unlike circulating blood neutrophils, express and produce IL-23, but not 87 
IL-12. We also report that supernatants from TLR8-activated neutrophils promote the 88 
differentiation of Th17 cells from naïve T cells, a finding that adds a new dimension 89 
to the ability of these cells to regulate immune functions during infections and 90 
inflammation.  91 
92 
MATERIALS AND METHODS  93 
 94 
Cell Purification and culture. Highly-purified neutrophils were isolated from the 95 
venous blood or from buffy coats from healthy individuals using a combined method 96 
consisting of Ficoll-Paque gradient centrifugation, dextran or Hetasep (StemCell 97 
Technologies, Vancouver, Canada) sedimentation of granulocytes and hypotonic lysis 98 
of erythrocytes, followed by removal of contaminating immune cells using the 99 
EasySep neutrophil enrichment kit (StemCell Technologies, Vancouver, Canada) as 100 
described previously19, 20. This procedure yields neutrophils of approximately 99.7% 101 
purity. Human monocytes were isolated from PBMCs, after Ficoll-Paque gradient 102 
centrifugation, by anti-CD14 microbeads (Miltenyi Biotec, Bergisch Gladbach, 103 
Germany) to reach > 98 % purity. Neutrophils and monocytes were then suspended 104 
at 5×106/ml and 2.5×106/ml respectively, in RPMI 1640 medium containing 10 % (< 105 
0.5 EU/ml endotoxin fetal bovine serum (BioWhittaker-Lonza, Basel, Switzerland). 106 
Cells were incubated for periods of up to 48 h (as indicated in the text) in the absence 107 
(control) or presence of 0.25-10 μM R848 (InvivoGen, San Diego, CA, USA), 0.25-108 
10 μM CL075 (InvivoGen), 0.25-10 μM VTX-2337 (Selleck Chem, Boston, MA, 109 
USA), 1 μg/ml LPS (ultrapure, E. coli 0111:B4 strain, InvivoGen), 10 ng/ml TNFD 110 
(R&D Systems, Minneapolis, MN, USA) or 10 μg/ml adalimumab (Humira, Abbott 111 
Biotechnology Limited, Barceloneta, Puerto Rico).  112 
 113 
Cell viability. Cell viability was assessed by flow cytometry using Vybrant 114 
DyeCycleTM Violet (Thermo Fisher Scientific, Waltham, MA, USA) and SYTOX 115 
AADvanced (Thermo Fisher Scientific) stain, as previously described 14. 116 
 117 
RNA isolation. After incubation as described in the text, neutrophils were pelleted 118 
by centrifugation, and total RNA was extracted with either Trizol or RNeasy mini 119 
kit (Qiagen, Venlo, Limburg, Netherlands). To completely remove any possible 120 
contaminating DNA, an on-column DNase digestion with the RNase-free DNase 121 
set (Qiagen) was performed during total RNA isolation.  122 
 123 
RT-qPCR. Total RNA was reverse-transcribed into cDNA using Superscript III 124 
(Thermo Fisher Scientific) and random hexamer primers (Thermo Fisher 125 
Scientific). Transcript levels of individual genes were measured by RT-qPCR using 126 
specific primer pairs (Thermo Fisher Scientific or Bio-Rad, Hertfordshire, UK) 127 
listed in Table 1. Data were calculated by Q-Gene software (http://www.gene-128 
quantification.de/download.html) and expressed as mean normalized expression 129 
units after RPL32 normalization.  130 
 131 
RNA-seq. Prior to RNA-seq, total RNA was enriched for mRNA using poly(A) 132 
selection. Standard Illumina (San Diego, CA, USA) protocols were used to generate 133 
50 bp single-end read libraries. In brief, mRNA was fragmented, reverse transcribed, 134 
adapted with sequencing primers and sample barcodes, size selected, and PCR-135 
enriched. Libraries were sequenced on the Illumina HiSeq 2000 platform. Reads were 136 
mapped to the reference human genome (hg19) using TopHat version 2.0.14 and 137 
Bowtie 2 version 2. Gene expression values [Fragments Per Kilobase of transcript per 138 
Million mapped reads (FPKM)] were calculated using Cufflinks version 2.02. A 139 
minimum FPKM threshold of expression of ≥ 0.3 was applied to the expression data 140 
to minimize the risk of including false positives against discarding true positives from 141 
the datasets.  142 
 143 
Immunoblotting experiments. Total proteins from neutrophils and monocytes 144 
were recovered from protein-rich flow-through solutions obtained after the first 145 
centrifugation step of the RNeasy mini kit procedure (Qiagen, used for total RNA 146 
extraction), as previously described 11. Proteins were then immunoblotted by 147 
standard procedures using the anti-human IRF8 pAbs (kindly provided by Prof. G 148 
Natoli from Humanitas University, Milan), and anti-human β-actin mAbs (A5060 149 
from Sigma, Saint Louis, MO, USA). Blotted proteins were detected by the 150 
Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE, USA) 11. 151 
 152 
Chromatin immunoprecipitation (ChIP) Assays. Chromatin 153 
immunoprecipitation experiments were performed exactly as previously described 154 
11. Briefly, nuclear extracts from formaldehyde-fixed 2.5-10 × 106 neutrophils were 155 
immunoprecipitated using 4 μl anti-PU.1 (sc-352) or anti-H3K27Ac (ab4729) pAbs 156 
(Abcam, Cambridge, United Kingdom). Coimmunoprecipitated material was 157 
subjected to qPCR analysis using the specific primers listed in Table 2 (purchased 158 
from Thermo Fisher Scientific). Data from qPCR are expressed as percentage over 159 
input DNA and are displayed as mean ± SEM. 160 
 161 
ChIP-seq. Purified DNA from PU.1 and H3K27Ac ChIP assays (performed as 162 
described in the previous paragraph) was adapter-ligated and PCR-amplified for 163 
sequencing on HiSeq2000 platform (Illumina, Cambridge, UK) using TruSeq DNA 164 
Library Prep Kit (Illumina). After sequencing, reads were quality-filtered according to 165 
the Illumina pipeline. Single end (51 bp) reads were then mapped to the human 166 
genome (Genome Reference Consortium GRCh37, Feb/2009) using BOWTIE v1.0.0. 167 
Only reads with no more than two mismatches (when compared to the reference 168 
genome) were converted to tag directories using HOMER’s module known as 169 
“makeTagDirectory,” and then converted to BedGraph format using HOMER’s 170 
module known as “makeUCSCfile,” to be finally normalized to 107 total tag counts. 171 
ChIP-seq signals were visualized using Integrative Genomics Viewer.  172 
 173 
Cytokine production. Cytokine concentrations in cell-free supernatants were 174 
measured by commercially available ELISA kits, specific for human: IL-175 
1E(eBioscience, San Diego, CA, USA), IL-23 (Mabtech, Nacka Strand, Sweden), 176 
IL-23A/IL-23p19 (Abcam, Cambridge, United Kingdom), TGFE(R&D 177 
Systems),IL-6, IL-12/IL-12p70 and IL-12B/IL-12p40  (Mabtech). Lower detection 178 
limits of these ELISA were: 4 pg/ml for IL-1E, 4 pg/ml for IL-23, 20 pg/ml for IL-179 
23A, 31 pg/ml for TGFE8 pg/ml for IL-6, 6 pg/ml for IL-12 and 10 pg/ml for IL-180 
12B.  181 
 182 
Functional Assays. Isolation of CD4+ T cells from PBMCs of umbilical cord blood 183 
(UCB) was performed by using the CD4 isolation kit II  (Miltenyi Biotec). After 184 
washing, cells were separated by immunomagnetic cell sorting (Miltenyi Biotec). 185 
Purified UCB-derived CD4+ T cells were incubated for 1 week with 5 Pg/ml of anti-186 
CD3 plus 5 Pg/ml anti-CD28 mAbs, in the absence or the presence of either 10 ng/ml 187 
IL-1E plus 20 ng/ml IL-23 (R&D Systems), or the indicated conditioned media from 188 
neutrophils and monocytes. In some experiments, anti-human IL-23 p19 antibodies 189 
(R&D Systems) were used in culture at the final concentration of 10 Pg/ml. On day 7, 190 
T cells were stimulated with 10 ng/ml PMA plus 1 PM ionomycin for 6 h, the last 4 h 191 
in the presence of 5 Pg/ml brefeldin A, and then analyzed for intracellular IL-17, in 192 
association with CD161 membrane expression, by BD LSRII flow cytometry with 193 
FACS Diva software (BD Biosciences, Franklin Lakes, NJ, USA), as previously 194 
described 21, 22.  195 
 196 
Statistical Analysis. Data are expressed as mean ± SEM. Statistical evaluation was 197 
performed by using, depending on the experimental data, Student’s t test, 1-way 198 
ANOVA followed by Tukey’s post hoc test or 2-way ANOVA followed by 199 
Bonferroni’s post hoc test. P values < 0.05 were considered as statistically 200 
significant. 201 
 202 
Study Approval. Human samples were obtained following informed, written, 203 
consent by healthy donors in accordance with the Declaration of Helsinki. This study 204 
was carried out in accordance with the recommendations of Committee on Research 205 
Ethics (CORE, University of Liverpool), Ethic Committee of the Azienda 206 
Ospedaliera Universitaria Integrata di Verona (Italy) and the Regional Committee on 207 
Human Experimentation (Florence, Italy).  208 
  209 
RESULTS  210 
Human neutrophils incubated with R848 and other TLR8 agonists are induced 211 
to express IL12B and IL23A, but not IL12A, mRNA. 212 
In initial experiments, we incubated highly pure human neutrophils in the absence 213 
(control) and the presence of 5 PM R848 - in line with our previous studies 11, 13 - and 214 
then measured changes in global gene expression by RNA-seq at 7 h and 20 h. Under 215 
these experimental conditions, survival rate of neutrophils was higher than 75 % and 216 
20 % after, respectively, 20 and 44 h of incubation 14. Notably, in R848-treated 217 
neutrophils, mRNAs for IL23A and IL12B, the constituent components of IL-2323, 218 
were expressed at remarkably high levels at both time-points (Fig. 1A, and data not 219 
shown). By contrast, mRNA levels of IL12A, the chain associating with IL12B to 220 
form IL-12 24, were at, or below, the detection limit and cut-off threshold FPKM 221 
values (< 0.3) in both control and R848-treated neutrophils (Fig. 1A). We then 222 
performed kinetic experiments by RT-qPCR (Fig. 1B), which not only confirmed the 223 
RNA-seq data, but also indicated that the optimal incubation time with R848 to 224 
induce maximal expression of IL12B and IL23A mRNAs in human neutrophils is 12 225 
h. Consistent with the RNA-seq data (Fig. 1A), IL12A remained substantially 226 
undetectable at all time-points investigated (Fig. 1B). Interestingly, induction of 227 
IL12B and IL23A mRNAs by R848 was only detected after 3 h of incubation (Fig. 228 
1B), which, at least in the case of IL12B, is consistent with the necessity to 229 
preliminarily activate the synthesis of INB]25. Incubation of human neutrophils with 230 
other TLR8 ligands, such as 1 PM CL07526 or 2 PM Motolimod/VTX-233727 showed 231 
similar results (data not shown). Collectively, these data demonstrate that highly pure 232 
human neutrophils incubated with R848 express the mRNAs encoding the chains 233 
composing IL-23, but not IL-12.  234 
 235 
The IL23A and IL12B genomic loci of human neutrophils are characterized by 236 
latent enhancers 237 
To identify and characterize, at a whole genome level, changes in the genomic 238 
regulatory regions of neutrophils following incubation with R848, we performed 239 
ChIP-seq experiments (NT et al, manuscript in preparation) for the genome-wide 240 
mapping of both histone 3 lysine 27 acetylation (H3K27Ac, marking active cis-241 
regulatory elements) and PU.1 (a myeloid lineage determining TF). Based on the 242 
results shown in Fig. 1, we analyzed the levels of the H3K27Ac and PU.1 peaks at the 243 
IL12A, IL12B and IL23A genomic loci, to infer precise information of their chromatin 244 
status in neutrophils. As shown in Fig. 2A, no PU.1 or H3K27Ac peaks were 245 
detectable at the IL12A locus, regardless of the neutrophil-treatment with R848. This 246 
finding indicates an inactive genomic region, in line with the absence of IL12A 247 
transcription as shown in Fig. 1A and B, as well as Fig. 2A. By contrast, the levels of 248 
H3K27Ac and PU.1 at the genomic regulatory regions of both IL12B and IL23A were 249 
found in a latent state 28, being very low in untreated neutrophils (Fig. 2B and C), but 250 
dramatically increased following neutrophil incubation with R848. This was 251 
especially evident at the genomic regions located at 12, 29 and 31 kb from the IL12B 252 
TSS (Fig. 2B), and at 2.5 and 5.5 kb from the IL23A TSS (Fig 2 C). Altogether, data 253 
from these ChIP-seq experiments not only are in line with the results shown in Fig. 1, 254 
but also support the notion that, in human neutrophils, chromatin re-modelling 255 
regulates IL12B and IL23A mRNA induction by R848, similarly to that previously 256 
observed for IL-6 11. 257 
 258 
Neutrophils incubated with R848 produce IL-23, but not IL-12. 259 
We then prepared cell-free supernatants harvested from neutrophils and (as control) 260 
autologous CD14+ monocytes to measure the levels of IL-12B, IL-12 and IL-23 by 261 
specific ELISA kits (Fig. 3). In these experiments, cells were also incubated with 1 262 
Pg/ml ultrapure LPS, to compare its activity to that of R848. Neutrophils incubated 263 
for 20 h with R848 were found to produce and release both IL-23 and IL-12B, but not 264 
IL-12 (Fig. 3A), with IL-23 and IL-12B levels further increasing after 44 h incubation 265 
(Fig. 3A). A similar qualitative pattern of neutrophil-derived cytokines was observed 266 
in response to LPS, but at lower levels (Fig. 3A). Measurements of the IL-23A 267 
monomer in supernatants from unstimulated or LPS- and R848-stimulated neutrophils 268 
for 20 h (1.7 ± 0.6, 17.4 ± 6.1 and 23.6 ± 5.5 pg/ml, respectively) did not substantially 269 
differ from that of the IL-23 heterodimer. Additional experiments confirmed that 5 270 
PM R848 represent the optimal concentrations to induce the production of IL-23 and 271 
IL-12B by neutrophils (data not shown), and that other TLR8 agonists, including 1 272 
PM CL07526 or 2 PM VTX-233727, also potently induce the release of these cytokines 273 
(data not shown). Not surprisingly 26, 29, CD14+ monocytes incubated with R848 and 274 
LPS produced much higher amounts of both IL-23 and IL-12B than neutrophils (Fig. 275 
3B). However, in contrast to neutrophils, activated CD14+ monocytes also produced 276 
IL-12, particularly in response to R848 (Fig. 3B), confirming previous observations 277 
26. Accordingly, we found that monocytes do accumulate IL12A mRNA upon TLR8 278 
activation (data not shown), consistent with similar observations made by other 279 
groups 30, 31. We also observed that CD14+ monocytes, unlike neutrophils (Fig. 3B), 280 
express high levels of IRF8, a transcription factor that, by interacting with IRF1 at the 281 
IL23A genomic locus, is essential for IL-12A transcription 32. Altogether, these data 282 
show that human neutrophils treated with R848 produce IL-23, but not IL-12, protein.  283 
 284 
3.5 Biological activity of neutrophil-derived supernatants 285 
Because IL-23, along with IL-1E, is involved in promoting the differentiation of Th17 286 
cells 33, we tested whether supernatants harvested from neutrophils and, for 287 
comparison, autologous CD14+ monocytes, could induce umbilical cord blood (UCB)-288 
derived naïve CD4 T cells to differentiate into Th17 cells 22. For these experiments, 289 
UCB-derived naïve CD4 T cells were polyclonally stimulated with anti-CD3 and anti-290 
CD28 mAbs and cultured in medium in the absence, or the presence, of IL-1E plus 291 
IL-23 as a positive control (Fig. 4A, top panels), as well as in supernatants derived 292 
from either neutrophils or CD14+ monocytes incubated for 24 h with or without R848 293 
(Fig. 4A, bottom panels). Previous measurement of IL-1E in supernatants from R848-294 
treated neutrophils and monocytes revealed concentrations of 11.6 pg/ml and 1.3 295 
ng/ml, respectively. We also found IL-6 levels corresponding to 180 pg/ml and 200 296 
ng/ml in R848-stimulated neutrophils and monocytes, respectively, while TGFE1 297 
levels were below the threshold limit of the ELISA used. As shown in Fig. 4A, only 298 
supernatants from R848-treated neutrophils were capable of inducing the appearance 299 
of cord blood-derived Th17 cells (from 1 to 6 %, n=4), as determined by the induction 300 
of intracellular IL-17 associated with an increased expression of CD161 (a Th17 301 
marker)22. By contrast, supernatants from either untreated neutrophils, or 302 
CD14+monocytes, regardless of their treatment with R848, had no effects on Th17 303 
induction (Fig. 4A). Similar results were observed by using neutrophil-derived 304 
supernatants harvested after 48 h of incubation with R848 (data not shown). Finally, 305 
the addition of anti-IL-23p19 neutralizing antibodies to supernatants from R848-306 
treated neutrophils drastically reduced the frequency of cord blood-derived Th17 cells 307 
(Fig. 4B). Altogether, these data indicate that supernatants from R848-treated 308 
neutrophils, but not CD14+monocytes, are able to promote the differentiation of Th17 309 
cells, mainly in an IL-23-dependent fashion.   310 
 311 
Effect of endogenous and exogenous TNFD on TLR8-induced IL-23 mRNA and 312 
protein expression.  313 
Previous work has uncovered a role for endogenous TNFD in amplifying 314 
R848-induced expression of IL-6 11. Therefore, to verify whether endogenous TNFD 315 
also regulates the production of IL-23, we incubated neutrophils with R848 for 20 h, 316 
in the presence or the absence of 10 Pg/ml adalimumab, a TNFD neutralizing 317 
antibody 34. Fig. 5A shows that the expression of IL-23 and IL-12B proteins, induced 318 
by R848, is largely dependent on endogenous TNFD (IL-23 and IL-12B protein 319 
decreased by 79 % and 70 %, respectively in the presence of adalimumab). Fig. 5B 320 
shows that such adalimumab-mediated inhibitory effect also occurs at the level of 321 
mRNA expression for both IL23A and IL12B (IL23A and IL12B mRNA on average 322 
decreased by 80 % and 73 %, respectively, by adalimumab). We subsequently 323 
incubated neutrophils with or without R848, in the presence or the absence of 10 324 
ng/ml TNFD, to further investigate the direct ability of TNFD to trigger the 325 
expression/production of IL-12 family members. As shown in Fig. 5C, exogenous 326 
TNFD alone was able to trigger both IL-23 and IL-12B expression, albeit at lower 327 
levels than R848. However, the combination of R848 plus TNFD produced a 328 
synergistic/additive effect on the production/release of both IL-23 and IL-12B (Fig. 329 
5C), and these effects were mirrored at the mRNA level (Fig. 5D). Nonetheless, in the 330 
in vitro model of Th17 differentiation from UCB-derived CD4+ T cells, supernatants 331 
from R848 plus TNFD-treated neutrophils did not increase the frequency of IL-17 332 
producing cells compared to supernatants derived from neutrophils treated with R848 333 
only (Figure 4B). Once again, neither expression of IL12A mRNA, nor production of 334 
IL-12 was detectable by neutrophils incubated with R848 plus TNFD (Fig. 5C and 335 
5D). In parallel experiments, we incubated neutrophils with or without R848, in the 336 
presence or the absence of 10 ng/ml GM-CSF. However, GM-CSF by itself was 337 
unable to trigger the expression/production of IL12A, IL12B and IL23A, and it also 338 
did not potentiate the effects of R848 on the same genes/proteins (data not shown).  339 
To get more insights into the molecular mechanisms underlying the synergistic 340 
induction of both IL12B and IL23A mRNA transcription by R848 plus TNFD we 341 
performed H3K27Ac and PU.1 ChIP-qPCR experiments targeting selected regulatory 342 
regions of the neutrophil IL12B (indicated by the black, white and grey boxes in Fig. 343 
6A) and IL23A (indicated by the black and white boxes in Fig. 6C) loci. These 344 
regions were chosen on the basis of the high deposition of PU.1 and H3K27Ac 345 
observed in our ChIP-seqs (Fig. 2). As shown in Figure 6, we found that either TNFD, 346 
or (more efficiently) R848, alone triggers an increase of the levels of H3K27Ac and 347 
PU.1 at all regulatory regions of both IL12B (Fig. 6B) and IL-23A (Fig. 6D). 348 
Costimulation of neutrophils with R848 plus TNFD further raised the levels of 349 
H3K27Ac and PU.1 already induced by either R848 or TNFD alone, resulting in an 350 
additive effect.  351 
  352 
DISCUSSION  353 
We have recently discovered that activation of highly pure human neutrophils 354 
with TLR8 triggers the production of remarkable quantities of cytokines, including 355 
TNFD, IL-6, G-CSF and CCL23 11, 13, 14. In this study, we demonstrate that, under the 356 
same experimental conditions, human neutrophils also express and produce IL-23, 357 
one of the members of the IL-12 family that is generated from the association of the 358 
IL-23A/IL-23p19 and IL-12B/IL-12p40 subunits. By contrast, human neutrophils 359 
were found not to express IL-12/IL-12p70, which are derived from the association of 360 
the IL-12A/IL-12p35 and IL-12B/IL-12p40 subunits. We show that TLR8-activated 361 
neutrophils are induced to time-dependently express transcripts for IL12B (encoding 362 
IL-12p40) and IL23A (encoding IL-23p19), but not IL12A (encoding IL-12p35), as 363 
determined by RNA-seq and RT-qPCR experiments. We also show that they produce 364 
and release the corresponding proteins, IL-12B, IL-23A and IL-23, but not IL-12, as 365 
determined by ELISA. Incubation of highly pure human neutrophils with LPS (a 366 
TLR4 agonist) also induced similar patterns of expression, although the amounts of 367 
IL-12B, IL-23A and IL-23 recovered in neutrophil-derived supernatants were lower 368 
than those measured after stimulation with TLR8 agonists. In contrast, autologous 369 
CD14+ monocytes incubated with either R848 or LPS were found to produce IL-23A, 370 
IL-12B and IL-23 at much higher levels than neutrophils. However, while in 371 
neutrophils R848 was a more potent trigger of IL-23 production than LPS, in 372 
monocytes both agonists had near equal potency. Moreover, CD14+ monocytes could 373 
also produce IL-12, but, consistent with the literature 30, 31, 35, only if incubated with 374 
TLR8 agonists. These differences in cellular responses to different agonists clearly 375 
demonstrate that the results obtained with our highly pure neutrophil populations are 376 
not due to their potential contamination with CD14+ monocytes. That neutrophils 377 
express IL12B and IL23A, but not IL12A, mRNA, in response to either TLR8 or 378 
TLR4 activation implicate intracellular signaling cascades triggered by the MyD88-379 
dependent pathway 36. Signaling via this pathway leads in fact to the activation of 380 
NFNB and MAPKs, which ultimately regulate the transcription of IL-12p40, IL-23p19 381 
37-39. In contrast, the induction of IL12A gene expression by TLR activation in 382 
myeloid cells is usually dependent on endogenous type I IFN 40, whose production, at 383 
least in the case of TLR4 activation results from the stimulation of the TRIF-384 
dependent pathway 41. For reasons that are not yet explained at the molecular level, 385 
LPS-treated neutrophils are unable to trigger the TRIF-dependent cascade and 386 
consequently do not produce type I IFN 42, 43. Similarly, while monocytes stimulated 387 
by TLR8 agonists produce type I IFN via IRF5 activation 44, it is not known whether 388 
this pathway is somewhat defective in human neutrophils. In any case, the lack of 389 
type I IFN production would contribute to the explanation as to why human 390 
neutrophils do not express IL-12A mRNA in response to either TLR8 or TLR4 391 
activation. Another potential explanation for the inability of neutrophils to accumulate 392 
IL-12A mRNA is that they do not express IRF8, a transcription factor that, in 393 
association with IRF1 at the IL12A locus, is essential for IL-12A transcription in 394 
monocytes32. 395 
We performed ChIP-seq experiments to characterize the H3K27Ac and PU.1 396 
levels at the IL12A, IL12B and IL23A genomic loci, in order to identify their genomic 397 
regulatory regions28. Our experiments revealed that the IL12B and IL23A loci are in a 398 
latent state in unstimulated neutrophils, and that, upon TLR8 activation, they become 399 
not only accessible to lineage determining transcription factors, such as PU.1, but also 400 
become marked by histone modifications characteristic of active genomic regions 401 
(H3K27Ac). Therefore, as in the case of IL-6 mRNA expression11, changes in the 402 
chromatin landscape induced by R848 appear to regulate IL12B and IL23A mRNA 403 
induction in human neutrophils. By contrast, we found that the IL12A locus remained 404 
inactive regardless of neutrophil-treatment with R848, and therefore preventing 405 
IL12A mRNA transcription, consistent with our RNA-seq and RT-qPCR data. In this 406 
respect, the chromatin status of the IL12A locus in human neutrophils resembles that 407 
of IL-10, which we have previously shown to be in a closed/inactive conformation, 408 
preventing its transcription 45. Moreover, because of the lack of IL12A gene 409 
expression, it is plausible to speculate that TLR4/TLR8-activated neutrophils do not 410 
even produce IL-35, which is another heterodimeric cytokine of the IL-12 family 411 
composed by the association of the IL-12A and EBI3 subunits. 412 
In additional experiments, we incubated neutrophils with GM-CSF, alone, or 413 
in combination with R848, and found that GM-CSF neither induced the expression of 414 
IL12A, IL12B and IL23A mRNA, nor influenced the effects of R848 on the same 415 
genes. In contrast, the use of a TNFD neutralizing antibody, adalimumab34, 416 
demonstrated that the production of IL-23 by TLR8-activated neutrophils is partially 417 
dependent on the endogenous expression and release of TNFD. Adalimumab 418 
decreased the production of IL-23 protein by approximately 70 %, and also decreased 419 
levels of IL12B and IL23A transcripts. The effect of adalimumab on IL-23 production 420 
is reminiscent of that on IL-6, for which endogenous TNFD was also shown to play an 421 
amplifying role 11, 14. However, while TNFD exogenously added to neutrophils was 422 
unable by itself to trigger the production of IL-6 11, it was able to induce IL-23 423 
expression, albeit at much lower levels than R848. Moreover, when used in 424 
combination with R848, exogenous TNFD resulted in a synergistic effect on the 425 
production and release of IL-23 by enhancing the expression of both IL12B and IL23A 426 
transcripts. Such a different capacity of exogenous TNFD to trigger low levels of IL-427 
23, but not IL-6, mRNA expression/production, might be explained by the fact that in 428 
resting human neutrophils, the chromatin at the IL6 genomic locus is inaccessible 11, 429 
while that at the IL12B and IL23A genomic loci is more opened and thus accessible to 430 
low levels of transcription via signal dependent transcription factors (SDTFs), such as 431 
NF-NB. Accordingly, we observed that TNFDis able to activate the regulatory 432 
regions at both IL12B and IL23A genomic loci, by recruiting PU.1 and by favoring the 433 
deposition of H3K27Ac. Notably, we also observed that TNFDfurther enhanced the 434 
effects triggered by R848 at the same regions, explaining the enhanced transcription 435 
at these regions in the presence of both agonists. On the other hand, the stimulation of 436 
neutrophils with TNFDtogether with R848 did not induce either the expression of 437 
IL12A mRNA or the IL-12 production, indicating that even the combination of these 438 
two potent stimuli is not sufficient to provoke a chromatin remodeling at the IL12A 439 
locus. 440 
Since IL-23 represents one of the cytokines responsible for the differentiation 441 
of Th17 cells33, along with IL-1EIL-6 and TGFE, we tested whether supernatants 442 
harvested from R848-treated neutrophils could promote this process. Of note, in our 443 
system of Th17 induction 22, we detected the appearance of low but reproducible 444 
levels of Umbilical cord blood (UCB)-derived Th17 cells from naïve CD4+ T cells 445 
incubated for one week with supernatants from neutrophils cultured with R848, but 446 
not in medium from unstimulated cells. However, we did not observe the same effects 447 
on Th17 induction using supernatants from CD14+ monocytes cultured with or 448 
without R848. The findings that supernatants derived from neutrophils stimulated 449 
with R848 plus TNFDdid not increase the frequency of Th17 UCB-derived CD4+ T 450 
cells compared to the R848-stimulated only supernatants, despite the higher levels of 451 
IL-23, might be due to the fact that they contain additional cytokines negatively 452 
interfering with Th17 polarization. In fact, the Th17 differentiation obtained after 1 453 
week of in vitro culture derives from many polarizing signals on naïve CD4+ T cells 454 
and depends on the balance of different cytokines in the culture medium. Moreover, 455 
the experiments performed in the presence of anti-IL-23p19 neutralizing antibody 456 
clearly demonstrate that IL-23 present in supernatants from R848- (and R848 plus 457 
TNFD)-treated neutrophils is mainly responsible for their Th17-promoting effects, 458 
thus emphasizing previous findings on the crosstalk between neutrophils and Th17 459 
cells 46, 47. Accordingly, human neutrophils and Th17 cells have been previously 460 
shown to reciprocally chemoattract each other via the production of various 461 
chemokines, including CCL20 from neutrophils and CXCL8 from Th17 cells48. 462 
Moreover, GM-CSF and/or IFNJ derived from Th17 cells were shown to promote 463 
neutrophil survival as well as enhance various neutrophil effector functions 48. More 464 
recently, neutrophil-derived elastase has been shown to process DC-derived CXCL8 465 
into a truncated, potent Th17 cell–inducing form 49. Our current data on the ability of 466 
TLR8-activated neutrophils to also drive via IL-23 the differentiation of Th17 cells, is 467 
consistent with another study showing that Group B Streptococcus (GBS)–stimulated 468 
neonatal neutrophils induce robust Th1– and Th17–type responses in neonatal CD4+ 469 
T-cell and Treg populations through mechanisms involving cell–cell contact and 470 
soluble mediators 50, adding new knowledge on the regulation and activation of the 471 
neutrophil/Th17 cell crosstalk. It is now necessary to determine if such processes 472 
occur in vivo during inflammation or infections.   473 
 474 
Our data greatly extend previous observations on the ability of human 475 
neutrophils to express/produce IL-23. For example, it was previously shown that, 476 
while Helicobacter pylori Neutrophil Activating Factor (HP-NAP) triggers the 477 
expression of IL23p19 mRNA by human neutrophils51, Borrelia burgdorferi NapA, 478 
but not OspA, induces IL-23 at both gene expression and protein level52. In another 479 
study, both blood neutrophils and neutrophils infiltrating colon tissue of pediatric 480 
patients with inflammatory bowel disease were found to express IL-23p19 (as 481 
revealed by immunohistochemistry and immunofluorescence)53, using an antibody 482 
detecting only the IL-23p19 monomer, which is secreted by many cell types but is 483 
biologically inactive. More recently, human neutrophils (whose purity was not stated) 484 
were shown to express IL-23 (presumably IL-23p19) mRNA, as well as to produce 485 
very elevated levels of IL-23 protein, when infected with Mycobacterium tuberculosis 486 
(MTB) H37Rv or when incubated with either LPS or Pam3CSK4 (a TLR2 agonist)54. 487 
However, in these experiments the infected neutrophils were also reported to express 488 
IL-1754, which, according to our previous work55, does not occur. Finally, 489 
immunofluorescence and flow cytometry analyses revealed that, in patients with 490 
castration-resistant prostate cancer (CRPC), tumour-infiltrating myeloid-derived 491 
suppressor cells (MDSCs) with the neutrophil phenotype (CD11b+CD33+CD15+ cells, 492 
PMN-MDSCs) express IL-2356.  493 
In summary, we show that highly pure neutrophils express IL-23, which is 494 
capable of driving the differentiation of Th17 cells. The expression of this key 495 
cytokine by human neutrophils requires chromatin remodeling at the normally 496 
transcriptionally silent IL-23 gene loci by agents such as TLR8 agonists. These data 497 
clearly support the role for neutrophils in the regulation of inflammation via the 498 
important IL-17/IL-23 network.   499 
 500 
 501 
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  730 
Figure Legends 731 
Figure 1. Expression of IL12A, IL12B and IL23A mRNA in neutrophils 732 
incubated with R848. In A, highly pure neutrophils were incubated for 20 h in the 733 
absence (-) or the presence of 5 μM R848. Expression levels of transcripts for IL12A 734 
(white bars), IL12B (grey bars) and IL23A (black bars) were measured by RNA-seq 735 
(n = 2). Similar results were observed from RNA-seq of neutrophils incubated with 736 
R848 for 7 h (n=2, not shown). In B, highly pure neutrophils were incubated for up to 737 
20 h in the presence or the absence of 5 μM R848, and then IL12A (B), IL12B (C) 738 
and IL23A (D) mRNA expression was measured by RT-qPCR. Gene expression is 739 
depicted as mean normalized expression (MNE) units after normalization to GAPDH 740 
mRNA (mean ± SEM, n = 3-13). Asterisks indicate significant differences: ** P < 741 
0.01, *** P < 0.001, by two-way ANOVA followed by Bonferroni’s post-test.  742 
 743 
 744 
Figure 2. ChiP-seq profiles of H3K27Ac and PU.1 at the IL12A, IL12B and 745 
IL23A genomic loci in human neutrophils incubated with or without R848. 746 
Genomic snapshots showing PU.1 and H3K27Ac peaks, as well as mRNA expression 747 
levels for IL12A (A), IL12B (B) and IL23A (C), in neutrophils incubated for 20 h in 748 
the absence (-) or the presence of R848. Changes in the regulatory regions (boxed in 749 
A, B and C) of the IL23A and IL12B genes, but not the IL12A gene, can be observed 750 
in human neutrophils following treatment with R848. 751 
 752 
 753 
Figure 3. Human neutrophils produce and release IL-23, but not IL-12, in 754 
response to either R848 or LPS. Highly pure neutrophils (A) and autologous CD14+ 755 
monocytes (B) were incubated for 20 and 44 h in the absence (-) or the presence of 756 
either 5 μM R848 or 1 Pg/ml LPS. Cell-free supernatants were then collected and the 757 
levels of IL-23, IL-12B and IL-12 proteins measured by ELISA (n = 6). * P < 0.05, 758 
** P < 0.01, *** P < 0.001, by two-way ANOVA followed by Bonferroni’s post-test. 759 
(E) Immunoblot displaying IRF8 and actin protein expression in neutrophils and 760 
autologous CD14+ monocytes, either freshly isolated or cultured for up to 20 h with or 761 
without 5 PM R848 (representative experiment, n = 2). 762 
 763 
 764 
Figure 4. Biological activity of neutrophil-derived supernatants 765 
Umbilical cord blood (UCB)-derived CD4+ T cells were incubated for 1 week with 5 766 
Pg/ml of anti-CD3 plus 5 Pg/ml anti-CD28 mAbs, (A) in the absence or the presence 767 
of 10 ng/ml IL-1E plus 20 ng/ml IL-23, or the indicated conditioned supernatants 768 
derived from neutrophils or CD14+ monocytes incubated with or without R848 for 20 769 
h; (B) in the absence or the presence of 10 ng/ml IL-1E plus 20 ng/ml IL-23, or the 770 
indicated conditioned supernatants derived from neutrophils incubated with or 771 
without R848, or R848  plus TNFD for 20 h and used in culture in the presence or 772 
absence of 10 Pg/ml neutralizing human anti-IL-23p19 antibody. Intracellular IL-17 773 
production and CD161 expression were evaluated by flow cytometry after stimulation 774 
with PMA plus ionomycin (see M&M). Representative experiments out of four and 775 
two are shown in panels A and B, respectively. 776 
 777 
 778 
Figure 5. R848-induced production of IL-23 by neutrophils is partially 779 
dependent on, and amplified by, TNFD. Highly pure neutrophils (A,B) were pre-780 
incubated for 30 min with 10 Pg/ml adalimumab and then cultured for 20 h in the 781 
presence of either 5 μM R848 or 10 ng/ml TNFD. In (C,D), neutrophils were 782 
incubated for 20 h in the absence (-) or the presence of R848, 10 ng/ml TNFD, or both 783 
agonists in combination. The levels of IL-23 (A, C), IL-12B (A, C) and IL-12 (C) 784 
proteins were measured by ELISA (n = 6), while (B) IL23A (B, D), IL12B (B, D) and 785 
IL12A (D) mRNA expression was determined by RT-qPCR (n = 6). Gene expression 786 
is depicted as mean normalized expression (MNE) units after normalization with 787 
GAPDH mRNA (mean ± SEM). ** P < 0.01, *** P < 0.001, by (A, B) one-way 788 
ANOVA followed by Tukey’s post-test or (C, D) two-way ANOVA followed by 789 
Bonferroni’s post-test.  790 
 791 
Figure 6. H3K27Ac and PU.1 levels at the IL12B and IL23A genomic loci of 792 
neutrophils incubated with R848, alone or in combination with TNFD. 793 
(A, C) Schemes illustrating the positions of the designed primer pairs amplifying 794 
promoter and potential enhancer regions of IL12B (indicated by the black, white and 795 
grey boxes) and IL23A (indicated by the black and white boxes) for ChIP analysis. 796 
Panels B and D show the enrichment levels of H3K27Ac (left panels) and PU.1 (right 797 
panels) at the IL12B (A) and IL23A (C) genomic loci by chromatin 798 
immunoprecipitation (ChIP) analysis in human neutrophils incubated for 20 h with or 799 
without 5 μM R848 and/or 10 ng/ml TNFD. Coimmunoprecipitated DNA samples 800 
were expressed as percent of the total input. Panels in B and D depict a representative 801 
experiment out of three independent ones with similar results. Error bars represent SE 802 
calculated from triplicate qPCR reactions. 803 
  804 
Table 1: List of human primer sets utilized for the RT-qPCR experiments.  805 
RT-qPCR 
primers 
Sequences 
forward primers reverse primers 
IL12A CTGGACCACCTCAGTTTGG TTTGTCGGCCTTCTGGAG 
IL12B GGACATCATCAAACCTGACC AGGGAGAAGTAGGAATGTGG 
IL23A GGACACATGGATCTAAGAGAAGAG CTATCAGGGAGCAGAGAAGG 
RPL32 AGGGTTCGTAGAAGATTCAAGG GGAAACATTGTGAGCGATCTC 
 806 
 807 
Table 2: List of human primer sets utilized for qPCR of ChIP assay.  808 
 809 
 810 
 811 
 812 
 813 
ChIP primer 
name 
Location 
(relative to the 
gene TSS) 
Sequence 
forward primers reverse primers 
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